Medicare Enrolled
Dr. Aarti Shevade, M.D.,
Medical Oncology · Wynnewood, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Shevade from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shevade?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Shevade
Dr. Aarti Shevade is a medical oncology specialist in Wynnewood, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Shevade performed 93,497 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Shevade received a total of $12,999 from 85 pharmaceutical and/or device companies across 641 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Shevade is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 1% volume in PA
$12,999 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗93,497
Medicare services
Top 1% in PA for medical oncology
Not available
Unique patients (not deduplicated)
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
56,250 | $1 | $4 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
22,840 | $2 | $21 |
| Denosumab injection (Prolia/Xgeva) | 5,400 | $19 | $69 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
4,374 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,060 | $1 | $122 |
| Injection, granisetron hydrochloride, 100 mcg | 1,030 | $0 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
583 | $101 | $224 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
428 | $24 | $152 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
241 | $12 | $93 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
235 | $13 | $105 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
229 | $111 | $686 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
135 | $52 | $304 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
125 | $1 | $7 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
122 | $1 | $9 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
113 | $75 | $148 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
91 | $24 | $156 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
90 | $55 | $334 |
| New patient office visit, complex (60-74 min) | 55 | $176 | $432 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
41 | $146 | $418 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $146 | $301 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
25 | $109 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
61.1% high complexity
37.9% medium
1.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$12,999
Total received (2018-2024)
Avg $1,857/year across 7 years
Top 28% in PA for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
85
Companies
641
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,191
2023
$2,935
2022
$1,971
2021
$269
2020
$600
2019
$1,856
2018
$2,177
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$308
Eisai Inc.
$250
Novartis Pharmaceuticals Corporation
$225
Genentech USA, Inc.
$195
Astellas Pharma US Inc
$191
Janssen Biotech, Inc.
$186
ABBVIE INC.
$160
GENZYME CORPORATION
$153
Regeneron Healthcare Solutions, Inc.
$118
Takeda Pharmaceuticals U.S.A., Inc.
$100
PFIZER INC.
$85
Lilly USA, LLC
$74
SOBI, INC
$74
Daiichi Sankyo Inc.
$72
Celgene Corporation
$71
Novocure Inc.
$64
PUMA BIOTECHNOLOGY, INC.
$63
Mirati Therapeutics, Inc.
$55
BeiGene USA, Inc.
$53
EMD Serono, Inc.
$51
Genmab U.S., Inc.
$44
Incyte Corporation
$39
Immunocore Limited
$38
GlaxoSmithKline, LLC.
$35
Ipsen Biopharmaceuticals, Inc
$35
Exelixis Inc.
$34
E.R. Squibb & Sons, L.L.C.
$33
Gilead Sciences, Inc.
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
ImmunoGen, Inc.
$30
TerSera Therapeutics LLC
$27
SpringWorks Therapeutics, Inc.
$25
Deciphera Pharmaceuticals Inc.
$24
SERVIER PHARMACEUTICALS LLC
$24
Fennec Pharmaceuticals, Inc.
$23
Tempus AI, Inc
$23
Merck Sharp & Dohme LLC
$23
Kite Pharma, Inc.
$21
ADC Therapeutics America, Inc.
$20
Stemline Therapeutics Inc.
$19
Acrotech Biopharma Inc.
$19
Rigel Pharmaceuticals, Inc.
$18
Secura Bio, Inc.
$15
Coherus Biosciences Inc.
$14
Top 3 companies account for 24.5% of 2024 payments
All-time payments by company (2018-2024) ›
Celgene Corporation
$1,109
Genentech USA, Inc.
$940
AstraZeneca Pharmaceuticals LP
$787
E.R. Squibb & Sons, L.L.C.
$686
Merck Sharp & Dohme Corporation
$638
Lilly USA, LLC
$603
Novartis Pharmaceuticals Corporation
$592
Eisai Inc.
$500
GENZYME CORPORATION
$476
PFIZER INC.
$421
Astellas Pharma US Inc
$415
Incyte Corporation
$399
Janssen Biotech, Inc.
$331
Amgen Inc.
$274
GlaxoSmithKline, LLC.
$259
Regeneron Healthcare Solutions, Inc.
$236
Seagen Inc.
$216
EISAI INC.
$203
Takeda Pharmaceuticals U.S.A., Inc.
$201
Merck Sharp & Dohme LLC
$189
ABBVIE INC.
$175
JAZZ PHARMACEUTICALS INC.
$175
Pharmacyclics LLC, An AbbVie Company
$162
Seattle Genetics, Inc.
$162
Daiichi Sankyo Inc.
$158
Blueprint Medicines Corporation
$146
Kite Pharma, Inc.
$133
Gilead Sciences, Inc.
$127
Ipsen Biopharmaceuticals, Inc
$120
Bayer Healthcare Pharmaceuticals Inc.
$117
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
Pharmacyclics LLC, an AbbVie Company
$88
Karyopharm Therapeutics Inc.
$87
Foundation Medicine, Inc.
$77
SOBI, INC
$74
TESARO, Inc.
$73
Mirati Therapeutics, Inc.
$73
BeiGene USA, Inc.
$73
Stemline Therapeutics Inc.
$68
Genmab U.S., Inc.
$67
Novocure Inc.
$64
PUMA BIOTECHNOLOGY, INC.
$63
Epizyme, Inc.,
$55
EMD Serono, Inc.
$51
Exelixis Inc.
$48
Dova Pharmaceuticals
$47
Rigel Pharmaceuticals, Inc.
$40
MorphoSys, US Inc.
$40
Taiho Oncology, Inc.
$40
Acrotech Biopharma Inc.
$39
Immunocore Limited
$38
Agios Pharmaceuticals, Inc.
$36
Adaptive Biotechnologies Corporation
$33
Organon LLC
$32
Bayer HealthCare Pharmaceuticals Inc.
$31
ImmunoGen, Inc.
$30
Heron Therapeutics, Inc.
$27
TerSera Therapeutics LLC
$27
SpringWorks Therapeutics, Inc.
$25
Alexion Pharmaceuticals, Inc.
$25
Deciphera Pharmaceuticals Inc.
$24
SERVIER PHARMACEUTICALS LLC
$24
G1 Therapeutics, Inc.
$24
Fennec Pharmaceuticals, Inc.
$23
Global Blood Therapeutics, Inc.
$23
Tempus AI, Inc
$23
Spectrum Pharmaceuticals Inc.
$23
Mylan Institutional Inc.
$22
PharmaEssentia USA Corporation
$21
Pharmacosmos Therapeutics Inc.
$20
Sobi, Inc
$20
Verastem, Inc.
$20
ADC Therapeutics America, Inc.
$20
Kyowa Kirin, Inc.
$20
Myovant Sciences Inc.
$19
MEDIVATION FIELD SOLUTIONS LLC
$19
Amneal Pharmaceuticals LLC
$18
Acrotech Biopharma LLC
$18
AVEO Pharmaceuticals, Inc.
$18
EUSA Pharma (US) LLC
$17
Sumitomo Pharma America, Inc.
$16
Cumberland Pharmaceuticals, Inc.
$15
Teva Pharmaceuticals USA, Inc.
$15
Secura Bio, Inc.
$15
Coherus Biosciences Inc.
$14
Top 3 companies account for 21.8% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Alecensa · Avastin · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRUKINSA · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · CHANTIX · CINVANTI · COPIKTRA · COSELA · CYRAMZA · Cabometyx · Copiktra · DOPTELET · Doptelet · ELAHERE · ELIQUIS · ELITEK · ELREXFIO · ELZONRIS · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · Enhertu · Epkinly · Erleada · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FULPHILA · Fabhalta · GAZYVA · GILOTRIF · HEMADY · Halaven · Herceptin · IBRANCE · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Idhifa · Imbruvica · Inrebic · Itovebi · JAKAFI · JEVTANA · Jivi · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NINLARO · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Optune · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · PYRUKYND · Padcev · Pedmark · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · QINLOCK · Quzyttir · REBLOZYL · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · SPRYCEL · SUTENT · Stivarga · Sylvant · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TUKYSA · Tivdak · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · Vanflyta · Vectibix · Venclexta · XPOVIO · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
120
County median income
$111,521
Nearest hospital to ZIP centroid (approximate)
MAIN LINE HOSPITAL LANKENAU
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Shevade is a mixed practice specialist, with above-average Medicare volume (top 1% in PA), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Shevade experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Shevade performed 56,250 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Shevade receive payments from pharmaceutical companies?
Yes. Dr. Shevade received a total of $12,999 from 85 companies across 641 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shevade's costs compare to other medical oncologists in Wynnewood?
Dr. Shevade's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shevade) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Wynnewood
Browse medical oncologists in Wynnewood ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in PA
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in PA
Which PA medical oncologists receive the most from drug and device companies.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology